Shiv Texchem Peer Comparison

BSE: 544272

₹110.65

₹-3.60 (-3.15%)

As on 28-Sep-2026 14:32IST

Market cap

₹265 Cr

Revenue (TTM)

₹2,202 Cr

P/E Ratio

3.4

P/B Ratio

0.6

Div. Yield

0 %

Edit

	Shiv Texchem	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality
Market cap (₹ Cr)	265	95	70	50	33,877
Revenue (₹ Cr)	2,202	18	1	35	4,974
Net Profit (₹ Cr)	48.11	-1.19	1.49	5.90	804.14
Net Margin (%)	2.18	-5.82	67.60	15.67	15.54
RoE (%)	18.30	--	3.36	14.76	18.21
Price to Earnings	3.40	--	46.96	8.50	42.39
Price-To-Book	0.64	13.94	1.54	1.21	6.86

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Shiv Texchem	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality
Operating Revenue	2,201.62	28.20	6.16	33.99	4,612.63
Total Income	2,204.80	28.24	6.18	36.34	4,671.80
Total Expenditure	2,115.50	27.95	5.56	29.88	3,765.88
EBITDA	86.11	0.25	0.60	4.11	846.75
Depreciation	0.23	1.03	0.03	0.36	54.97
EBIT	85.88	-0.78	0.56	3.75	791.78
Interest	23.45	0.59	0.00	0.34	44.77
Other Income	3.19	0.04	0.02	2.35	59.17
Exceptional Items	--	-1.07	--	--	--
Profit before Tax	65.62	-2.40	0.58	5.77	806.18
Provision for Tax	17.51	-0.30	0.15	1.52	251.08
Profit after Tax	48.11	-2.09	0.43	4.25	555.10

Liabilities (₹ Cr)

	Shiv Texchem	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality
Shareholder's Funds	332.84	-1.99	44.83	35.56	3,721.74
Minority Interest	--	--	--	--	49.20
Non-Current Liabilities	94.84	7.51	1.38	0.57	593.04
Current Liabilities	825.84	13.04	0.69	6.95	736.24
Total Liabilities	1,253.58	18.75	46.92	43.07	5,100.22

Assets (₹ Cr)

	Shiv Texchem	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality
Non-Current Assets	2.76	8.56	0.05	2.67	2,817.58
Current Assets	1,250.77	10.00	46.85	40.40	2,282.64
Total Assets	1,253.58	18.75	46.92	43.07	5,100.22
Total Debt*	409.25	8.09	0.90	4.21	308.70
Net Current Assets	424.93	-3.03	46.16	33.46	1,546.40
Contingent Liabilities	333.59	--	0.41	1.09	50.60

Cashflow (₹ Cr)

	Shiv Texchem	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality
Cash From Operating Activities	-116.02	-0.96	2.11	-5.83	446.86
Cash Flow from Investing Activities	-0.28	-0.70	-20.97	0.46	-235.20
Cash from Financing Activities	181.01	1.40	43.67	1.35	-271.49
Net Cash Inflow / Outflow	64.70	-0.26	24.81	-4.02	-59.84

Ratios

Profitability Ratios

	Shiv Texchem	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality
ROCE (%)	14.46	-29.88	2.44	16.58	22.17
ROE (%)	18.30	0.00	1.87	12.58	16.62
ROA (%)	4.69	-12.36	1.70	10.57	11.16
EBIT Margin (%)	4.06	1.04	10.02	19.01	19.64
Net Margin (%)	2.18	-7.41	6.98	11.68	11.88
Cash Profit Margin (%)	2.20	-3.77	7.56	13.54	13.23

Growth Ratios

	Shiv Texchem	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality
Revenue Growth (%)	43.44	155.17	-64.31	-8.18	10.22
EBIT Growth (%)	49.25	108.86	62.49	-22.82	31.75
Net Profit Growth (%)	60.12	63.59	68.04	-27.53	35.17
EPS Growth (%)	17.93	63.59	-42.03	-27.53	34.94
Book Value Growth (%)	72.58	-346.40	3,563.74	11.34	19.46

Valuation Ratios

	Shiv Texchem	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality
Price / Earnings	11.83	0.00	141.99	17.28	37.68
Price / Book Value	1.71	-5.86	1.37	2.06	5.76
Dividend Yield (%)	0.00	0.00	0.00	0.87	0.14
EV/EBITDA	8.21	80.88	59.87	11.15	22.71
Market Cap (₹ Cr)	568.90	15.80	61.28	73.37	20,933.97

Solvency Ratios

	Shiv Texchem	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality
Debt to Equity	1.23	-4.07	0.02	0.12	0.08
Short term debt to equity ratio	0.93	--	--	0.10	0.08
Current Ratio	1.51	0.77	67.45	5.82	3.10
Quick Ratio	0.92	0.51	67.45	5.55	2.31
Interest Coverage	3.80	-3.09	371.96	18.07	19.01

Operating Efficiency Ratios

	Shiv Texchem	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality
Debtors to sales (%)	20.19	4.53	0.13	12.22	13.72
Asset Turnover	2.15	1.66	0.24	0.85	0.93
Receivable days	51.95	20.01	49.30	55.72	50.98
Inventory Days	73.91	36.94	0.00	19.39	50.95
Payable days	63.88	149.20	74.11	45.04	46.50
Cash Conversion Cycle	61.99	-92.25	-24.81	30.08	55.43

Annual
Quarterly